PMID: 17138220

Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.

Jonat Walter, Gnant Michael, Boccardo Francesco, Kaufmann Manfred, Rubagotti Alessandra, Zuna Ivan, Greenwood Mike, Jakesz Raimund

The Lancet. Oncology · 2007

Vol. 7, Issue 12, pp. 991-6

View on PubMed DOI

This entry links to third-party literature. For research use only.

AnastrozoleAntineoplastic Agents, HormonalBreast NeoplasmsDisease ProgressionDisease-Free SurvivalFemaleHumansNitrilesPostmenopauseRandomized Controlled Trials as Topic

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.